| Date | Time | Source | Headline | Symbol | Company |
| 06/09/2008 | 2:31PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 06/09/2008 | 7:00AM | Business Wire | Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/14/2008 | 6:55PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/13/2008 | 6:13PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/12/2008 | 5:28PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/08/2008 | 4:05PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Quarterly Report (10-Q) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/08/2008 | 4:03PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/08/2008 | 4:00PM | Business Wire | Nastech Announces First Quarter 2008 Financial Results | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/01/2008 | 4:00PM | Business Wire | Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008 | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/30/2008 | 5:19PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/30/2008 | 5:18PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/29/2008 | 1:50PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Proxy Statement (definitive) (DEF 14A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/25/2008 | 8:00AM | Business Wire | Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/18/2008 | 6:04AM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/02/2008 | 4:53PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 04/02/2008 | 4:52PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/27/2008 | 8:00AM | Business Wire | Nastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/25/2008 | 12:41PM | Business Wire | Nastech Pharmaceutical Company Inc. to Present RNAi Data | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/21/2008 | 4:00PM | Business Wire | Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/19/2008 | 4:47PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/18/2008 | 9:36PM | Business Wire | Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/17/2008 | 4:09PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Annual Report (10-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/17/2008 | 4:03PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/17/2008 | 4:00PM | Business Wire | Nastech Announces Fourth Quarter and Full Year 2007 Financial Results | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/13/2008 | 8:00AM | Business Wire | Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/11/2008 | 8:00AM | Business Wire | Nastech Pharmaceutical Company Inc. Completes Key RNAi Patent Filings | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/10/2008 | 4:17PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/07/2008 | 8:00AM | Business Wire | Nastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi Subsidiary | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 03/04/2008 | 5:27PM | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 02/29/2008 | 2:23PM | PR Newswire (US) | Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, Ma | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |